Skip to content

XP Inc

US · XP #1395 by market cap Listed 2019
29.53 -0.20 -0.67%
Live - 5344 symbols - heartbeat 260s ago · 2026-10-08 07:28
Pre-market 29.17 -1.22%
After-hours 29.55 +0.07%
Overnight 29.53 0.00%
Market cap
14.98B
P/B
3.03
EPS
1.94
Reader sentiment Are you bullish or bearish on XP?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
17.23 fair value ≈ 28.89 40.56
  • Implied fair-value range of 17.23-40.56, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +2.2% above the average-multiple fair value of 28.89.

Valuation each multiple against its own 5-year range

P/B ratio 2.87 In line with history 55th percentile
5-year average 7.67 · #58 of 93 in Capital Markets
P/E ratio 13.87 In line with history 57th percentile
5-year average 14.91 · forward 11.93 · #20 of 43 in Capital Markets
P/S ratio 8.47 In line with history 57th percentile
5-year average 8.72 · forward 3.37 · #69 of 94 in Capital Markets

Vs. peers Capital Markets

Company Market cap P/E (TTM) P/B Div yield
XP Inc (XP) 14.98B 14.61 3.03 1.33%
Morgan Stanley (MS) 297.95B 15.32 2.80 2.11%
Goldman Sachs (GS) 258.33B 13.70 2.35 1.92%
Charles Schwab (SCHW) 165.29B 17.41 3.76 1.23%
Robinhood (HOOD) 98.46B 48.46 10.39 0.00%
Interactive Brokers (IBKR) 39.75B 34.82 6.73 0.37%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value27.80 Economic moatNone UncertaintyHigh

Trading 5.9% above Morningstar's fair value estimate.

Fair value

XP Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 1% premium over our quantitative fair value estimate of $27.80 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The company's lack of profitability decreases our estimated valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's sales yield of 14.1% ranks in the bottom 20% compared with global peers. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our view that shares are expensive.

Conversely, the firm's valuation metrics are reassuring. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to market value ratio of 1.9, for example, ranks in the top 20% globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. Despite our unfavorable price/fair value ratio, this characteristic is a positive attribute.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:28:21 · For reference only, not investment advice and not tailored to your situation.